Pharmaceutical
Compounding
Solutions that deliver clear visibility and control for the preparation of Compounded Sterile Products (CSPs)
The United States Pharmacopeia establishes standards for pharmaceutical compounding to protect patient safety and product sterility. USP <797> Pharmaceutical Compounding Sterile Preparations defines requirements for sterile compounding environments, aseptic technique, and air quality, with the most recent revision enforceable as of November 1, 2023. USP <800> Hazardous Drugs Handling in Healthcare Settings sets standards for the safe handling of hazardous drugs to minimize exposure to healthcare personnel, patients, and the environment.
Baker supports pharmaceutical professionals with containment and clean air solutions designed to align with current USP <797> and USP <800> requirements, helping pharmacies maintain compliant environments for the aseptic preparation of hazardous and non hazardous compounded medications.
To optimize the validation and documentation of sterile compounding procedures, Baker integrates with a variety of IV workflow management systems as well as Pharmacy Verification Software. Built in fully integrated IV prep software keeps the compounding environment clean with no wires or devices within the hood. Usable compounding space is left unaltered. A powerful 5 megapixel imaging system that closely focuses in on the names, numbers, labels, color and other details of drugs and syringes is utilized.
The integrated systems include image recognition and barcode scanning features as well as a storage and retrieval image system that allows for documentation of the compounding process for quality purposes. The compounding status dashboard is automatically updated and easily accessible from desktops, laptops, tablets, and mobile devices. The integrated systems are scalable and modular allowing flexibility to adapt to the customer environment.
When working with hazardous pharmaceutical compounds, chemotherapy agents, or IV mixtures that can be harmful to pharmacy personnel, a contained and leak-tight negative pressure work area is required. Baker’s barrier isolator creates a unidirectional HEPA-filtered airflow of better than ISO Class 5 (class 100) air cleanliness conditions within the
negative pressure chamber to prevent migration of hazardous contaminants to the outside and minimize cross-contamination in the direct compounding area. Clean technology designs improve the pharmaceutical compounding process by offering the finest environmental protection to the pharmacy laboratory.
